Track the Green Thumb Industries Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Industrials sector, Green Thumb Industries Inc. has logged 163 public disclosures. Market capitalisation: €1.6bn. The latest transaction was disclosed on 8 June 2026 (56 - Grant of rights). Among the most active insiders: Kovler Benjamin. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 163 declarations
Green Thumb Industries Inc. is a leading U.S. cannabis company listed on a U.S. market in the NYSE/NASDAQ universe for international investors, and headquartered in Chicago, Illinois, United States. Founded in 2014, Green Thumb has evolved into an integrated operator that combines consumer packaged goods, cultivation/production, and retail distribution. Its business model is built around branded products, controlled execution across the value chain, and a multi-state footprint in a still-fragmented but increasingly competitive industry. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/overview/default.aspx?utm_source=openai)) Green Thumb’s operations are centered on two main pillars: the manufacturing and distribution of branded cannabis products, and the operation of its RISE Dispensaries retail chain. The company highlights a portfolio of well-known brands including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon’s, and Good Green. This breadth allows Green Thumb to address several consumer segments, from premium flower and extracts to more accessible offerings and wellness-oriented products. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/overview/default.aspx?utm_source=openai)) From a competitive standpoint, Green Thumb is one of the more established operators in the U.S. cannabis sector, with meaningful scale across multiple states. Recent company disclosures indicate operations across 14 markets, more than 100 retail locations, and a manufacturing base that has ranged from the mid-teens to around 20 facilities depending on reporting date. That geographic diversification is strategically important because it reduces reliance on any single state market and provides a pathway to benefit from new state-level openings over time. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/overview/default.aspx?utm_source=openai)) Recent developments have underscored a focus on both growth and capital discipline. Green Thumb reported full-year 2024 results, highlighting positive operating cash flow and a solid liquidity position, and in September 2025 announced a $50 million share repurchase program. The company also continued to expand its retail footprint, including moves in Pennsylvania and Minnesota, reinforcing its strategy of selective market expansion and brand-led retail growth. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/news-and-events/press-releases/press-release-details/2025/Green-Thumb-Industries-Reports-Fourth-Quarter-and-Full-Year-2024-Results/default.aspx?utm_source=openai)) For investors, Green Thumb represents a relatively mature way to gain exposure to the U.S. cannabis opportunity: branded product power, vertically integrated operations, and a recognized retail platform. The key investment considerations remain regulatory uncertainty in the United States, state-by-state market complexity, and industry-wide margin pressure as competition intensifies. ([gtigrows.com](https://www.gtigrows.com/our-story/?utm_source=openai))